A Common Diabetes Drug May Reduce Long Covid Risk, Trial Data Finds

Share
  • December 27, 2022

Preliminary data from a randomized clinical trial may point to a potential way to prevent long covid. The trial found that covid-19 patients who took metformin, a commonly prescribed diabetes drug, were noticeably less likely to be diagnosed with long covid up to 10 months later than people in the control group. More…

Read more…

Source : A Common Diabetes Drug May Reduce Long Covid Risk, Trial Data Finds